公司资料
Cel-Sci Corporation 股价、新闻与催化剂
- 股票代码:
- CVM
- 交易所:
- AMEX
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.55 USD (+0.65%)
收盘价
最后更新: 2026年8月17日
21.6M USD
市值
股价为何变动
As of Aug 17, 2026, CVM closed up 0.65% at $1.55. No new same-company headline was identified in the current news window.
公司概览
业务概览
Cel-Sci is a biotechnology company focused on immunotherapy and cancer vaccine approaches. Its story has long centered on a high-risk, high-conviction immune-oncology platform.
所在地与行业分类
Headquartered in the United States and listed on NYSE American, Cel-Sci sits in oncology biotechnology.
商业模式特征
The company depends on clinical validation, regulatory progress, and the ability to create a differentiated immunotherapy story.
生物医药行业定位
Cel-Sci is a classic high-beta oncology name whose stock is extremely sensitive to trial outcomes.
未来催化剂
- Cel-Sci’s catalysts are Multikine-related regulatory or development steps, with any update on the head-and-neck cancer story being the key event. The company’s stock remains highly event-driven.
近期新闻
- 01
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。